TRANSCEND CAPITAL ADVISORS, LLC: CME position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TRANSCEND CAPITAL ADVISORS, LLC on CME, newest first. How the timeline and the estimate are built.
TRANSCEND CAPITAL ADVISORS, LLC held 3,350 CME shares at 2026-06-30 per its 13F-HR filed 2026-08-04.
the latest 13F is the newest step
- period ended2026-06-3013F 3,350 sharesChange vs previous 13F +24 shares
0.05% of the 13F portfolio, value $739,781.
13F-HR 0001776082-26-000004 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 3,326 sharesChange vs previous 13F +311 shares
0.08% of the 13F portfolio, value $982,271.
13F-HR 0001776082-26-000003 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 3,015 sharesChange vs previous 13F -40 shares
0.06% of the 13F portfolio, value $823,278.
13F-HR 0001776082-26-000001 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 3,055 sharesChange vs previous 13F +36 shares
0.06% of the 13F portfolio, value $825,439.
13F-HR 0001776082-25-000008 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,019 sharesChange vs previous 13F -304 shares
0.06% of the 13F portfolio, value $832,105.
13F-HR 0001776082-25-000004 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,323 sharesChange vs previous 13F +19 shares
0.06% of the 13F portfolio, value $881,488.
13F-HR 0001776082-25-000002 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 3,304 sharesChange vs previous 13F -556 shares
0.06% of the 13F portfolio, value $767,271.
13F-HR 0001776082-25-000001 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 3,860 sharesChange vs previous 13F not available
0.06% of the 13F portfolio, value $851,901.
13F-HR 0001776082-24-000007 filed by TRANSCEND CAPITAL ADVISORS, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).